The fibrinolytic pathway in the human fetus.
The fibrinolytic pathway and the protease inhibitors in 12 to 24-and 24-to 36-week-old fetuses were examined and compared with full-term newborns. The activity of the fibrinolytic system, as well as the values of the protease inhibitors approach the normal values progressively with the embryonic maturation.
D005312:Fetal Blood / Q000032:analysis*; D005342:Fibrinolysis; D006801:Humans; D007231:Infant, Newborn; D010447:Peptide Hydrolases / Q000097:blood; D011480:Protease Inhibitors
D011480:Protease Inhibitors; D010447:Peptide Hydrolases